Thank you for taking the time to provide insight on your treatment practices for patients undergoing bone marrow transplantation. Question Title * 1. When assessing a patient’s risk for infection after transplant, how important are the following factors when formulating their anti-infection treatment regimen? Not important Important Very important Prior history of infection Prior history of infection Not important Prior history of infection Important Prior history of infection Very important Local environmental factors (microbiota, climate, etc) Local environmental factors (microbiota, climate, etc) Not important Local environmental factors (microbiota, climate, etc) Important Local environmental factors (microbiota, climate, etc) Very important Prior history of prolonged neutropenia Prior history of prolonged neutropenia Not important Prior history of prolonged neutropenia Important Prior history of prolonged neutropenia Very important Older age Older age Not important Older age Important Older age Very important Graft-vs-host disease Graft-vs-host disease Not important Graft-vs-host disease Important Graft-vs-host disease Very important Prolonged neutropenia post-transplant Prolonged neutropenia post-transplant Not important Prolonged neutropenia post-transplant Important Prolonged neutropenia post-transplant Very important Graft source Graft source Not important Graft source Important Graft source Very important Question Title * 2. If a 66-year-old patient is presenting with ANC <100 cells/mm3 on Day 28 after an allogeneic transplant and has a history of bacterial pneumonia infections, which treatment approach(es) would you take? Please rank the options below in order of preference. ANC=absolute neutrophil count; G-CSF=granulocyte colony-stimulating factor; GM-CSF=granulocyte-macrophage colony-stimulating factor. Question Title * 3. At what point do you typically intervene to accelerate neutrophil recovery in a patient experiencing delayed engraftment with risk factors for infection after autologous or allogeneic transplant? Day 14-21 Day 21-28 Day 29-36 Day 37+ Other (please specify) Question Title * 4. How satisfied are you with current treatment options for: Not satisfied Satisfied Very satisfied Reducing the incidence of infection after autologous HCT Reducing the incidence of infection after autologous HCT Not satisfied Reducing the incidence of infection after autologous HCT Satisfied Reducing the incidence of infection after autologous HCT Very satisfied Reducing the incidence of infection after allogeneic HCT Reducing the incidence of infection after allogeneic HCT Not satisfied Reducing the incidence of infection after allogeneic HCT Satisfied Reducing the incidence of infection after allogeneic HCT Very satisfied Accelerating delayed engraftment Accelerating delayed engraftment Not satisfied Accelerating delayed engraftment Satisfied Accelerating delayed engraftment Very satisfied Treating graft failure Treating graft failure Not satisfied Treating graft failure Satisfied Treating graft failure Very satisfied HCT=hematopoietic stem cell transplant. Question Title * 5. How detrimental do you believe post-transplant infection is to the following factors for patients and their caregivers? Not detrimental Detrimental Very detrimental Dietary choices Dietary choices Not detrimental Dietary choices Detrimental Dietary choices Very detrimental Financial considerations Financial considerations Not detrimental Financial considerations Detrimental Financial considerations Very detrimental Interaction with pets Interaction with pets Not detrimental Interaction with pets Detrimental Interaction with pets Very detrimental Mental health Mental health Not detrimental Mental health Detrimental Mental health Very detrimental Overall quality of life Overall quality of life Not detrimental Overall quality of life Detrimental Overall quality of life Very detrimental Self-care Self-care Not detrimental Self-care Detrimental Self-care Very detrimental Time with family and friends Time with family and friends Not detrimental Time with family and friends Detrimental Time with family and friends Very detrimental Question Title * 6. Specialty type: Physician Physician Assistant Nurse Nurse Practitioner Pharmacist Other (please specify) Question Title * 7. Area of clinical focus: Hematology Oncology Medical Oncology Stem Cell Transplant Infectious Disease Other (please specify) Submit